Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCompass Group Regulatory News (CPG)

Share Price Information for Compass Group (CPG)

Share Price is delayed by 15 minutes
Get Live Data
32.74    0.52 (1.61%)
Bid:
32.70
Ask:
32.72
Spread: 0.02 (0.061%)
Market Cap: $55.67b
CPG Live PriceLast checked at - London Stock Exchange

Intraday Compass Group Share Chart

AGM and Q1 Trading Update

3 Feb 2022 07:00

RNS Number : 5220A
Compass Group PLC
03 February 2022
 

Legal Entity Identifier (LEI): No. 2138008M6MH9OZ6U2T68

 

 

 

 

 

 

 

3 February 2022

 

AGM and Q1 Trading Update

 

 

This statement updates investors on Compass Group PLC's performance for the three months ended 31 December 2021 and is being issued ahead of the Company's Annual General Meeting. The AGM will be held at 12 noon today at Twickenham RFU Stadium and will also be broadcast live via the Company's website.

 

Encouraging start to the year driven by continued improvementacross all sectors

 

 

 

Group organic revenue grew by 38.6%[1] in the first quarter, with revenues reaching 97% of their pre-COVID level[2]. The quarterly improvement was largely driven by new business, continued strong client retention along with some ongoing recovery in the base business. The emergence of the Omicron variant had a limited impact on the Group during the period.

 

By region

Organic revenue growth1

Revenue as % of 20192

 

Q4 2021

Q1 2022

Q4 2021

Q1 2022

North America

41.5%

51.1%

90%

102%

Europe

23.8%

25.0%

84%

89%

Rest of World

13.6%

10.6%

90%

89%

Group

32.9%

38.6%

88%

97%

 

Performance improved across all regions with four out of five sectors now trading above 100% of 2019 revenues2. Growth was particularly strong in North America in Sports & Leisure and Education. In Europe, all sectors traded well except for Business & Industry which continues to be impacted by reopening delays. The Rest of World region continued to benefit from a higher exposure to the more resilient Defence, Offshore & Remote sector.

 

By sector

Revenue as a % of 20192

Q4 2021

Q1 2022

Business & Industry

68%

77%

Education

94%

101%

Healthcare & Senior Living

111%

115%

Sports & Leisure

89%

107%

Defence, Offshore & Remote

109%

117%

Group

88%

97%

Future growth

 

In the first quarter, the Group spent c. £87 million on bolt-on acquisitions in North America, further strengthening our capabilities in delivered-in solutions. There is a strong pipeline of exciting opportunities across all regions and sectors, and we remain disciplined in our approach to acquisitions.

 

The acceleration in new business wins seen in FY21 continued into the new year, with three out of the five top wins globally coming from first time outsourcing.

 

Currency

 

Trading results from our overseas operations are translated at the average exchange rates for the period. If these currency movements[3] continue for the remainder of the year, foreign exchange translation would negatively impact 2021 revenue by £75 million and operating profit by £3 million.

 

Summary and outlook

We are encouraged by the strong start to the year, excellent new business wins and continued strong client retention. However, we are mindful of some impact from the Omicron variant in Q2, with Business & Industry clients delaying their return to work, some Sports & Leisure events being postponed and Education facilities extending remote learning.

Our guidance for FY22 remains unchanged. We expect full year organic revenue growth of 20 - 25%, with quarterly growth rates moderating through the year, reflecting more challenging comparatives. As previously stated, full year underlying operating margin is expected to be over 6%, returning to around 7% by the year end. Margin progression will be second half weighted, with the first half margin anticipated to be around the Q4 2021 exit rate.

Looking further ahead, we remain excited about the significant structural growth opportunities globally, leading to the potential for revenue and profit growth above historical rates, returning margin to pre-pandemic levels, and rewarding shareholders with further returns.

 

Our next reporting dates are:

 

11 May

Half Year Results

26 July

Q3 Trading Update

22 November

Full Year Results

 

Conference call:

 

The Company will hold a call with investors and analysts today at 8:00 a.m. (UK time).

 

Participant dial in numbers:

 

UK Toll Number:

 

+44 (0) 330 551 0200

UK Toll-Free Number:

 

0808 109 0700

US Toll Number:

 

+1 212 999 6659

US Toll-Free Number:

 

+1 866 966 5335

Participants do not require a PIN to enter the call, please reference "COMPASS".

 

Enquiries

 

Investors:

Agatha Donnelly & Simon Bielecki

+44 (0) 1932 573 000

Press:

Tim Danaher, Brunswick

+44 (0) 207 404 5959

Website:

www.compass-group.com

 

 

Notes to Editors

 

a) Compass Group PLC is a world leading food service company, which generated annual revenues of £18.1 billion in the year to 30 September 2021. It serves meals to millions of people in 45 countries and employs and engages with around 480,000 people. The Company specialises in providing food and a range of support services across the core sectors of Business & Industry, Healthcare & Senior Living, Education, Sports & Leisure and Defence, Offshore & Remote, with an established brand portfolio. 

b) Organic revenue, a term used throughout the announcement, is calculated by adjusting for acquisitions (excluding current period acquisitions and including a full period in respect of prior period acquisitions), sale and closure of businesses (excluded from both periods) and exchange rate movements (translating the prior period at current period exchange rates).

c) Forward looking statements:

Certain information included in this Announcement is forward looking and involves risks, assumptions and uncertainties that could cause actual results to differ materially from those expressed or implied by forward looking statements. Forward looking statements cover all matters which are not historical facts and include, without limitation; the direct and indirect impacts and implications of public health crises such as the coronavirus COVID-19 on the economy, nationally and internationally, and on the Group, its operations and prospects, including disruptions and inefficiencies in the supply chain; UK domestic and global political, economic and business conditions (such as the UK's exit from the EU); projections relating to results of operations and financial conditions and the Company's plans and objectives for future operations, including, without limitation, discussions of expected future revenues, financing plans, expected expenditures and divestments; risks associated with changes in economic conditions, the strength of the food and support services markets in the jurisdictions in which the Group operates; fluctuations in food and other product costs and labour costs; and prices and changes in exchange and interest rates. Forward looking statements can be identified by the use of forward looking terminology, including terms such as 'believes', 'estimates', 'anticipates', 'expects', 'forecasts', 'intends', 'plans', 'projects', 'goal', 'target', 'aim', 'may', 'will', 'would', 'could' or 'should' or, in each case, their negative or other variations or comparable terminology.

Forward looking statements in this Announcement are not guarantees of future performance. All forward looking statements in this Announcement are based upon information known to the Company on the date of this Announcement. Accordingly, no assurance can be given that any particular expectation will be met and readers are cautioned not to place undue reliance on forward looking statements when making their investment decisions. Additionally, forward looking statements regarding past trends or activities should not be taken as a representation or warranty that such trends or activities will continue in the future. Other than in accordance with its legal or regulatory obligations (including under the UK Listing Rules and the Disclosure Guidance and Transparency Rules of the Financial Conduct Authority), the Company undertakes no obligation to publicly update or revise any forward looking statement, whether as a result of new information, future events or otherwise. Nothing in this Announcement shall exclude any liability under applicable laws that cannot be excluded in accordance with such laws

d) A copy of this release, together with all other recent announcements and presentations can be found on Compass Group's website at www.compass-group.com.

 

 

These results are unaudited

[1] Year on year change

[2] On a constant currency basis, including all acquisitions and disposals

[3] Closing rates as at 28 January 2022

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTSSLFMEEESEIE
Date   Source Headline
1st Jun 20267:00 amRNSTotal Voting Rights
11th May 20267:00 amRNSHalf Year Results Announcement
1st May 20267:00 amRNSTotal Voting Rights
1st Apr 20267:00 amRNSChange in trading currency of Ordinary Shares
1st Apr 20267:00 amRNSTotal Voting Rights
18th Mar 20267:00 amRNSChange in trading currency of Ordinary Shares
6th Mar 202610:15 amRNSDirector/PDMR Shareholding
2nd Mar 20267:00 amRNSTotal Voting Rights
10th Feb 20262:00 pmRNSSterling Equivalent of Final Dividend
5th Feb 20262:42 pmRNSResult of AGM
5th Feb 20267:00 amRNSQ1 Trading Statement
2nd Feb 20267:00 amRNSTotal Voting Rights
20th Jan 202610:38 amRNSAnnual Financial Report 2025
15th Jan 202611:15 amRNSHolding(s) in Company
9th Jan 202611:45 amRNSDirector/PDMR Shareholding
2nd Jan 20267:00 amRNSTotal Voting Rights
2nd Jan 20267:00 amRNSTotal Voting Rights
17th Dec 202512:00 pmRNSAnnual Report 2025 and Notice of AGM 2026
8th Dec 20253:15 pmRNSDirector Declaration
5th Dec 20255:50 pmRNSDirector/PDMR Shareholding
1st Dec 20257:00 amRNSTotal Voting Rights
25th Nov 20252:30 pmRNSDirector/PDMR Shareholding
25th Nov 20257:00 amRNSFull Year Results
3rd Nov 20257:00 amRNSTotal Voting Rights
1st Oct 20257:05 amRNSTotal Voting Rights
1st Oct 20257:00 amRNSBlock listing Interim Review
26th Sep 20252:00 pmRNSBoard and Committee Changes
22nd Sep 20255:58 pmRNSHolding(s) in Company
12th Sep 20252:45 pmRNSDirector Declaration
1st Sep 20257:00 amRNSTotal Voting Rights
1st Aug 20257:00 amRNSTotal Voting Rights
22nd Jul 20257:00 amRNSQ3 Trading Update
22nd Jul 20257:00 amRNSCompass Group PLC agrees to acquire Vermaat Groep
15th Jul 20254:45 pmRNSSterling Equivalent of Interim Dividend
1st Jul 20257:00 amRNSTotal Voting Rights
2nd Jun 20257:00 amRNSTotal Voting Rights
14th May 20257:00 amRNSHalf Year Results Announcement
1st May 20257:00 amRNSTotal Voting Rights
2nd Apr 20252:30 pmRNSDirector Declaration
1st Apr 20259:00 amRNSBlock listing Interim Review
1st Apr 20257:00 amRNSTotal Voting Rights
21st Mar 20254:25 pmRNSDirector/PDMR Shareholding
3rd Mar 20257:00 amRNSTotal Voting Rights
13th Feb 20254:00 pmRNSDirector/PDMR Shareholding
11th Feb 20253:00 pmRNSSterling Equivalent of Final Dividend
6th Feb 20254:41 pmRNSResult of AGM
6th Feb 20257:00 amRNSTrading Statement
3rd Feb 20257:00 amRNSTotal Voting Rights
28th Jan 202511:30 amRNSAnnual Financial Report
2nd Jan 20257:00 amRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.